Correlation Between Symtek Automation and Synmosa Biopharma
Can any of the company-specific risk be diversified away by investing in both Symtek Automation and Synmosa Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Symtek Automation and Synmosa Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Symtek Automation Asia and Synmosa Biopharma, you can compare the effects of market volatilities on Symtek Automation and Synmosa Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Symtek Automation with a short position of Synmosa Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Symtek Automation and Synmosa Biopharma.
Diversification Opportunities for Symtek Automation and Synmosa Biopharma
-0.76 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Symtek and Synmosa is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Symtek Automation Asia and Synmosa Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synmosa Biopharma and Symtek Automation is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Symtek Automation Asia are associated (or correlated) with Synmosa Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synmosa Biopharma has no effect on the direction of Symtek Automation i.e., Symtek Automation and Synmosa Biopharma go up and down completely randomly.
Pair Corralation between Symtek Automation and Synmosa Biopharma
Assuming the 90 days trading horizon Symtek Automation Asia is expected to generate 3.48 times more return on investment than Synmosa Biopharma. However, Symtek Automation is 3.48 times more volatile than Synmosa Biopharma. It trades about 0.06 of its potential returns per unit of risk. Synmosa Biopharma is currently generating about -0.28 per unit of risk. If you would invest 19,900 in Symtek Automation Asia on September 4, 2024 and sell it today you would earn a total of 700.00 from holding Symtek Automation Asia or generate 3.52% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Symtek Automation Asia vs. Synmosa Biopharma
Performance |
| Timeline |
| Symtek Automation Asia |
| Synmosa Biopharma |
Symtek Automation and Synmosa Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Symtek Automation and Synmosa Biopharma
The main advantage of trading using opposite Symtek Automation and Synmosa Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Symtek Automation position performs unexpectedly, Synmosa Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synmosa Biopharma will offset losses from the drop in Synmosa Biopharma's long position.| Symtek Automation vs. Foxsemicon Integrated Technology | Symtek Automation vs. United Integrated Services | Symtek Automation vs. Ennostar | Symtek Automation vs. All Ring Tech |
| Synmosa Biopharma vs. GeneFerm Biotechnology Co | Synmosa Biopharma vs. Ruentex Development Co | Synmosa Biopharma vs. Symtek Automation Asia | Synmosa Biopharma vs. CTCI Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |